Global Interventional Neuroradiology Market To Cross USD 50 Billion By 2032 Delveinsight
The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is ...
The Lancet17m
Gene therapy for AMD: better as an adjuvant than a replacement – Authors' reply
We thank Huixun Jia and Xiaodong Sun for their perspective on our study.1 The goals of this first-in-human trial were to identify safe doses of RGX-314 and an optimised protocol for advanced studies.